Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
News Source : Financial Post
News Summary
- Dr. Fahar Merchant will present and participate in one-on-one meetings at the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8-10, 2025, at the Lotte New York Palace Hotel in New York City.
- Webcast and replay information for this event will also be available on the investor relations section of Medicenna’s website on the Events & Presentations page.
- Medicenna is a clinical-stage immunotherapy company focused on developing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines.
TORONTOandHOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) Medicenna Therapeutics Corp. (Medicenna or the Company) (TSX MDNA, OTCQX MDNAF), a clinicalstage cancer immunotherapy company focused on the de [+5415 chars]